Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Galactomannan detection for invasive aspergillosis in immunocompromized patients.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007394. doi: 10.1002/14651858.CD007394. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007394.

PMID:
18843747
2.

Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Leeflang MM, Debets-Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Zhang M, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2015 Dec 30;(12):CD007394. doi: 10.1002/14651858.CD007394.pub2. Review.

3.

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, Klingspor L, Morton O, Maertens J.

Cochrane Database Syst Rev. 2015 Oct 1;(10):CD009551. doi: 10.1002/14651858.CD009551.pub3. Review.

PMID:
26424726
4.

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, Klingspor L, Morton O, Maertens J.

Cochrane Database Syst Rev. 2015 Sep 7;(9):CD009551. doi: 10.1002/14651858.CD009551.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD009551.

PMID:
26343815
5.

Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

de Heer K, Gerritsen MG, Visser CE, Leeflang MM.

Cochrane Database Syst Rev. 2019 May 20;5:CD012399. doi: 10.1002/14651858.CD012399.pub2. Review.

PMID:
31107543
6.

[Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].

Rácil Z, Kocmanová I, Weinbergerová B, Winterová J, Lengerová M, Hrncírová K, Mayer J.

Klin Mikrobiol Infekc Lek. 2009 Apr;15(2):48-57. Czech.

PMID:
19488961
7.

Evaluation of serum galactomannan enzyme immunoassay at two different cut-offs for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.

Mohindra R, Capoor MR, Puri S, Raheja H, Gupta DK, Gupta B, Chowdhury R.

Indian J Med Microbiol. 2017 Apr-Jun;35(2):237-242. doi: 10.4103/ijmm.IJMM_17_47.

8.

[A systematic review of the accuracy of diagnostic test of serum galactomannan antigen detection for invasive aspergillosis].

Sun WK, Zhang F, Xu XY, Shen YY, Shi Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Oct;33(10):758-65. Review. Chinese.

PMID:
21176508
9.

Serum galactomannan for diagnosing invasive aspergillosis in pediatric patients: A meta-analysis.

Tong T, Shen J, Xu Y.

Microb Pathog. 2018 May;118:347-356. doi: 10.1016/j.micpath.2018.03.059. Epub 2018 Mar 31. Review.

PMID:
29614368
10.

Serum galactomannan levels in the diagnosis of invasive aspergillosis.

Okuturlar Y, Ozkalemkas F, Ener B, Serin SO, Kazak E, Ozcelik T, Ozkocaman V, Ozkan HA, Akalin H, Gunaldi M, Ali R.

Korean J Intern Med. 2015 Nov;30(6):899-905. doi: 10.3904/kjim.2015.30.6.899. Epub 2015 Oct 30.

11.

Utility of the Aspergillus galactomannan antigen testing for neutropenic paediatric patients.

Sav H, Atalay MA, Koc AN, Unal E, Demir G, Zararsiz G.

Infez Med. 2017 Mar 1;25(1):38-44.

12.

Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.

Suankratay C, Kanitcharaskul P, Arunyingmongkol K.

J Med Assoc Thai. 2006 Nov;89(11):1851-8.

PMID:
17205865
13.

Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study.

Teering S, Verreth A, Peeters A, Van Regenmortel N, De Laet I, Schoonheydt K, Dits H, Van De Vyvere M, Libeer C, Meersseman W, Malbrain ML.

Anaesthesiol Intensive Ther. 2014 Jul-Aug;46(3):145-54. doi: 10.5603/AIT.2014.0027.

14.

Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis.

Hayden R, Pounds S, Knapp K, Petraitiene R, Schaufele RL, Sein T, Walsh TJ.

Pediatr Infect Dis J. 2008 Sep;27(9):815-9. doi: 10.1097/INF.0b013e31817197ab.

PMID:
18703991
15.

Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.

Scotter JM, Campbell P, Anderson TP, Murdoch DR, Chambers ST, Patton WN.

Pathology. 2005 Jun;37(3):246-53.

PMID:
16175901
16.

[Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis].

Zhang XY, Zhao SY, Jiang ZF.

Zhonghua Er Ke Za Zhi. 2009 Feb;47(2):83-6. Chinese.

PMID:
19573449
17.

Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.

Eigl S, Hoenigl M, Spiess B, Heldt S, Prattes J, Neumeister P, Wolfler A, Rabensteiner J, Prueller F, Krause R, Reinwald M, Flick H, Buchheidt D, Boch T.

Med Mycol. 2017 Jul 1;55(5):528-534. doi: 10.1093/mmy/myw102.

18.

Real-time PCR on the first galactomannan-positive serum sample for diagnosing invasive aspergillosis in liver transplant recipients.

Botterel F, Farrugia C, Ichai P, Costa JM, Saliba F, Bretagne S.

Transpl Infect Dis. 2008 Oct;10(5):333-8. doi: 10.1111/j.1399-3062.2008.00323.x. Epub 2008 Jul 8.

PMID:
18627580
19.

Blood biomarkers for the non-invasive diagnosis of endometriosis.

Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, Mol BW, Johnson N, Hull ML.

Cochrane Database Syst Rev. 2016 May 1;(5):CD012179. doi: 10.1002/14651858.CD012179. Review.

PMID:
27132058
20.

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.

Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV.

Br J Haematol. 2004 Sep;126(6):852-60.

PMID:
15352990

Supplemental Content

Support Center